Navigation Links
Pressure BioSciences, Inc. to Discuss Second Quarter 2012 Financial Results and Provide Business Update
Date:8/13/2012

SOUTH EASTON, Mass., Aug. 13, 2012 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Second Quarter 2012 financial results and to provide a business update.  Anyone interested may listen to the teleconference either by telephone or through a live web-cast.  The teleconference and web-cast information is provided below:

Date:  Tuesday, August 14, 2012
Time: 4:30 p.m. Eastern Daylight Time (EDT)

To attend this teleconference via telephone:
Dial-in: 800-875-3456
Passcode (to be given to the operator): VS67260

For those unable to participate in the teleconference, a replay will be available approximately one hour after the call ends through September 14, 2012, and will be accessible through the Company's website. 

About Pressure BioSciences, Inc.Pressure BioSciences, Inc. ("PBI") (OTCQB: PBIO) is focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology ("PCT"). PCT is a patented, enabling technology platform with multiple applications in the estimated $6 billion life sciences sample preparation market. PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. PBI currently focuses its efforts on the development and sale of PCT-enhanced sample preparation systems (instruments and consumables) for mass spectrometry, biomarker discovery, bio-therapeutics characterization, vaccine development, soil and plant biology, forensics, histology, and counter-bioterror applications.For more information about PBI and this press release, please click on the following links:
http://www.pressurebiosciences.com  Investor Contacts: Richard T. Schumacher, President & CEO Pressure BioSciences, Inc.Joseph D
'/>"/>

SOURCE Pressure BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Failure to Take Medicine Linked to Unnecessary Hospital Visits, Especially for Medicare Patients Taking High Blood Pressure or High Cholesterol Medications
3. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
4. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
5. Negative Pressure Wound Therapy (NPWT) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
6. Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
7. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
8. MinuteClinic Joins with American Heart Association to Help Americans Reduce High Blood Pressure
9. Long-Term Use of Blood Pressure Medications that Promote Sun Sensitivity May Increase Risk of Lip Cancer in Non-Hispanic Whites
10. Social Norms, Life Changes and Increasing Pressures Contribute to Substance Abuse Among Adult Women
11. Founded by Enlight Biosciences, KNODE partners with AstraZeneca and Other Partners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... -- QT Vascular Ltd., together with its subsidiaries ("QT Vascular" ... design, assembly and distribution of advanced therapeutic solutions for ... into an agreement with a group of investors (the ... This funding will strengthen the Group,s working capital which ... Dr. Eitan Konstantino , Ph.D., ...
(Date:7/27/2015)... York , July 27, 2015 ... Research "Bionics Market - Global Industry Analysis, Size, Share, Growth, ... valued at USD 7.96 billion in 2014, growing at a ... USD 20.49 billion in 2021. The global bionics ... number of accidents, which is leading to paralysis or amputation ...
(Date:7/27/2015)... , July 27, 2015 Dynatronics Corporation (NASDAQ: DYNT ... Solaris therapeutic modality products. This approval allows the company to sell ... countries around the world. "Receiving the CE Mark represents ... stated Kelvyn H. Cullimore Jr. , president and CEO of ... network into China , Japan ...
Breaking Medicine Technology:QT Vascular Obtains Funding To Boost Growth Through Issuance of up to US$13.14 Million Convertible Bonds 2QT Vascular Obtains Funding To Boost Growth Through Issuance of up to US$13.14 Million Convertible Bonds 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 4Dynatronics Awarded CE Mark Approval for Its Solaris Products 2
... trauma or,noise-induced hearing loss. By any name, it,s the ... 28 million Americans,have impaired hearing; for as many as ... December 2007 issue of Harvard Men,s,Health Watch., Acoustic ... exposure,is the most common cause, but recreational noise -- ...
... Proven to Significantly Improve Overall Survival in ... Patients ... 19 ,Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq:,ONXX) today ... a supplemental New Drug Application for Nexavar(R) (sorafenib),tablets for the ...
Cached Medicine Technology:Your Hearing May be at Risk, Says Harvard Men's Health Watch 2Nexavar First FDA-Approved Drug Therapy for Liver Cancer 2Nexavar First FDA-Approved Drug Therapy for Liver Cancer 3Nexavar First FDA-Approved Drug Therapy for Liver Cancer 4Nexavar First FDA-Approved Drug Therapy for Liver Cancer 5Nexavar First FDA-Approved Drug Therapy for Liver Cancer 6
(Date:7/27/2015)... ... ... Throughout its 20 year history, Doctors on Liens has pioneered ... basis. As the personal injury and medical industries have changed, Doctors on Liens ... pain management physicians, to psychologists and more. And while many of these offices ...
(Date:7/27/2015)... ... July 27, 2015 , ... Recently, 10 Best Water ... respected water brands also made the organization’s list. As its name clearly indicates, 10 ... available. Here is a description of the top three brands, along with a listing ...
(Date:7/27/2015)... Dallas, Texas (PRWEB) , ... July 27, 2015 ... ... the use of fullerenes in medical and diagnostics applications is rapidly increasing and ... drug delivery and cancer treatment, they are increasingly being evaluated for use in ...
(Date:7/27/2015)... ... , ... Boston IVF, the first Massachusetts egg freezing center to assist in ... Nantucket Island for women who wish to learn more about their fertility and egg ... Chins Way, Nantucket Island 02554 from 4:30-6:30pm. , This casual and informative event will ...
(Date:7/27/2015)... ... 27, 2015 , ... Standifer Insurance Group, a locally owned insurance company with ... Conquest, a specialized camp for young people who have been hospitalized in the burn ... and four night curriculum designed to give burn survivors between the ages of 6-17 ...
Breaking Medicine News(10 mins):Health News:Doctors on Liens Adds Highly Respected Physical Therapy Office in Los Angeles 2Health News:Best Water Brand Awards Presented by 10 Best Water 2Health News:Fullerene Market to Grow at 13% CAGR to 2019 Says a New Research Report at Sandlerresearch.org 2Health News:Fullerene Market to Grow at 13% CAGR to 2019 Says a New Research Report at Sandlerresearch.org 3Health News:Boston IVF to Host Egg Freezing Event in Nantucket on August 6th at 4:30pm 2Health News:Boston IVF to Host Egg Freezing Event in Nantucket on August 6th at 4:30pm 3Health News:Standifer Insurance Group and Camp Conquest Plan Joint Charity Initiative to Assist Hospitalized Children Suffering from Burn Injuries 2Health News:Standifer Insurance Group and Camp Conquest Plan Joint Charity Initiative to Assist Hospitalized Children Suffering from Burn Injuries 3
... Volunteers Mount Winning Effort to Fight Skin Cancer, at LPGA,s ... ... Triumphs, HALF MOON BAY, Calif., Oct. 17 Volunteer,dermatologists, nurses, medical ... recent LPGA,s Samsung,World Championship in Half Moon Bay, CA to combat skin ...
... For centuries civilizations have,flocked to warm bubbly waters to ... the high tech home spas of today that can ... of economic uncertainty,is a backyard water oasis simply a ... any science behind the soak?, To view the ...
... from hair loss is now available in the UK for both men ... ... genetic test to identify those most at risk from hair loss is ... ,Currently only available at Farjo Hair Transplant Clinic , the simple, ...
... Blindness, LISBON, Portugal and NEW YORK, Oct. ... global science foundations, invites all,institutions working to combat ... Champalimaud Vision Award. The Award is given for ... and,visual impairment. The prestigious Award, which brings with ...
... 16 Americans United for Life,(AUL) today filed an ... regulation of the deadly abortion drug, RU-486., AUL ... track,record of ruining and even ending women,s lives. We ... this drug. Ohio,s statute is a,step in the right ...
... those relying on fixed incomes are particularly challenged by rising expenses, ... , ... Belleville, Ill. (Vocus) October 16, 2008 -- For ... Insurance (SSDI) or awaiting a decision on their application for benefits, ...
Cached Medicine News:Health News:Sun Safety Champions Team Up With LPGA Tour Pro Paula Creamer 2Health News:Sun Safety Champions Team Up With LPGA Tour Pro Paula Creamer 3Health News:Sun Safety Champions Team Up With LPGA Tour Pro Paula Creamer 4Health News:Video: The Science Behind the Soak - a Coping Tool for Today's Changing World 2Health News:Breakthrough Baldness Genetic Test 2Health News:The Champalimaud Foundation Invites Nominations and Applications for Its 2009 Vision Award 2Health News:The Champalimaud Foundation Invites Nominations and Applications for Its 2009 Vision Award 3Health News:Ohio's Regulation of RU-486 Clear and Constitutional, Should Be Upheld Argues AUL in Brief Filed Before Ohio Supreme Court 2Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 2Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 3Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 4Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 5Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 6Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 7
... Richmond Products includes the four demonstration plates, the ... for a total of 24 plates. Each of ... and clean page selection. The test also includes ... laminated copy of the score sheet. The score ...
... charts are recognized internationally as a ... deficiency. With normal color perception, the ... visible. Each color test plate in ... printed to measure incrementally higher color ...
Accepted by leading authorities as a simple and accurate method for discovering congenital color blindness of two type total color blindness and red/green blindness. This book is used for children an...
Accepted by leading authorities as a simple and accurate method for discovering congenital color blindness of two type total color blindness and red/green blindness. This book is used for children an...
Medicine Products: